TY  - JOUR
AU  - Guardamagna, Mora
AU  - Berciano-Guerrero, Miguel-Angel
AU  - Villaescusa-González, Beatriz
AU  - Perez-Ruiz, Elisabeth
AU  - Oliver, Javier
AU  - Lavado-Valenzuela, Rocío
AU  - Rueda-Dominguez, Antonio
AU  - Barragán, Isabel
AU  - Queipo-Ortuño, María Isabel
PY  - 2022
DO  - 10.3390/ijms231911990
UR  - http://hdl.handle.net/10668/21203
T2  - International journal of molecular sciences
AB  - Gut microbiome (GM) and its either pro-tumorigenic or anti-tumorigenic role is intriguing and constitutes an evolving landscape in translational oncology. It has been suggested that these microorganisms may be involved in carcinogenesis, cancer...
LA  - en
PB  - MDPI
KW  - Gut microbiome
KW  - Immune system
KW  - Metastatic melanoma
KW  - Anti-Bacterial Agents
KW  - Fecal Microbiota Transplantation
KW  - Gastrointestinal Microbiome
KW  - Humans
KW  - Immune Checkpoint Inhibitors
KW  - Immunotherapy
KW  - Melanoma
KW  - Mitogen-Activated Protein Kinase Kinases
KW  - Neoplasms, Second Primary
KW  - Protein Kinase Inhibitors
KW  - Proto-Oncogene Proteins B-raf
KW  - Tumor Microenvironment
TI  - Gut Microbiota and Therapy in Metastatic Melanoma: Focus on MAPK Pathway Inhibition.
TY  - research article
VL  - 23
ER  -